BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28739788)

  • 1. Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact.
    Galar A; Valerio M; Muñoz P; Alcalá L; García-González X; Burillo A; Sanjurjo M; Grau S; Bouza E
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
    Pea F; Cojutti PG; Baraldo M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
    Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
    J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of linezolid therapeutic drug monitoring in the treatment of MRSA tracheo-pulmonary infection in a 10-month-old infant.
    Castagnola E; Cangemi G; Bandettini R; Torre M; Zannini L; Tuo P; Moscatelli A
    J Chemother; 2016 Dec; 28(6):517-519. PubMed ID: 26431268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with high linezolid trough plasma concentrations.
    Morata L; De la Calle C; Gómez-Cerquera JM; Manzanedo L; Casals G; Brunet M; Cobos-Trigueros N; Martínez JA; Mensa J; Soriano A
    Expert Opin Pharmacother; 2016 Jun; 17(9):1183-7. PubMed ID: 27156708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.
    Blassmann U; Roehr AC; Frey OR; Koeberer A; Briegel J; Huge V; Vetter-Kerkhoff C
    Pharmacology; 2016; 98(1-2):51-5. PubMed ID: 27046487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants.
    Sicard M; Launay E; Caillon J; Jacqueline C; Legrand A; Deslandes G; Navas D; Rozé JC; Guen CG
    Eur J Clin Pharmacol; 2015 May; 71(5):611-5. PubMed ID: 25740677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus pneumonia with high doses of linezolid administered in continuous infusion.
    Álvarez-Lerma F; Muñoz-Bermúdez R; Samper-Sánchez MA; Gracia Arnilla MP; Grau S; Luque S
    Med Intensiva; 2017; 41(1):56-59. PubMed ID: 27269810
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit.
    Blanchard AC; Fortin E; Laferrière C; Goyer I; Moussa A; Autmizguine J; Quach C
    J Antimicrob Chemother; 2017 Jun; 72(6):1812-1817. PubMed ID: 28333257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution.
    Galar A; Muñoz P; Valerio M; Cercenado E; García-González X; Burillo A; Sánchez-Somolinos M; Juárez M; Verde E; Bouza E
    Int J Antimicrob Agents; 2019 Jan; 53(1):40-48. PubMed ID: 30243587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?
    Pea F; Cojutti P; Dose L; Baraldo M
    Br J Clin Pharmacol; 2016 Feb; 81(2):341-8. PubMed ID: 26469887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal meningitis therapy with linezolid in a young infant: efficacy, CSF levels and side effects.
    Auriti C; Piersigilli F; Bersani I; Cairoli S; Amante PG; Longo D; Goffredo BM
    Ital J Pediatr; 2020 Jun; 46(1):90. PubMed ID: 32600437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections.
    Lopez-Garcia B; Luque S; Roberts JA; Grau S
    J Infect; 2015 Nov; 71(5):604-7. PubMed ID: 26099449
    [No Abstract]   [Full Text] [Related]  

  • 15. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).
    Flamm RK; Mendes RE; Hogan PA; Streit JM; Ross JE; Jones RN
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2273-80. PubMed ID: 26833165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report.
    Xiao B; Deng P; Jin H; Wang H; Cao Y
    Am J Case Rep; 2018 Sep; 19():1117-1120. PubMed ID: 30232318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable Linezolid Exposure in Intensive Care Unit Patients-Possible Role of Drug-Drug Interactions.
    Töpper C; Steinbach CL; Dorn C; Kratzer A; Wicha SG; Schleibinger M; Liebchen U; Kees F; Salzberger B; Kees MG
    Ther Drug Monit; 2016 Oct; 38(5):573-8. PubMed ID: 27631464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of long-term treatment with linezolid in cystic fibrosis: case report.
    Spicuzza L; Sciuto C; La Rosa M
    J Chemother; 2008 Jun; 20(3):399-401. PubMed ID: 18606604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.